These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 7094203

  • 21. Absolute bioavailability of paracetamol after oral or rectal administration in healthy volunteers.
    Eandi M, Viano I, Ricci Gamalero S.
    Arzneimittelforschung; 1984; 34(8):903-7. PubMed ID: 6548636
    [Abstract] [Full Text] [Related]

  • 22. The effect of dietary protein on the clearance of allopurinol and oxypurinol.
    Berlinger WG, Park GD, Spector R.
    N Engl J Med; 1985 Sep 26; 313(13):771-6. PubMed ID: 4033706
    [Abstract] [Full Text] [Related]

  • 23. Single-dose kinetics and bioavailability of ketobemidone.
    Anderson P, Arnér S, Bondesson U, Boréus LO, Hartvig P.
    Acta Anaesthesiol Scand Suppl; 1982 Sep 26; 74():59-62. PubMed ID: 6124079
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
    Strenkoski-Nix LC, Ermer J, DeCleene S, Cevallos W, Mayer PR.
    Am J Health Syst Pharm; 2000 Aug 15; 57(16):1499-505. PubMed ID: 10965395
    [Abstract] [Full Text] [Related]

  • 25. Dosage prescribing and plasma oxipurinol levels in patients receiving allopurinol therapy.
    Peterson GM, Boyle RR, Francis HW, Oliver NW, Paterson J, von Witt RJ, Taylor GR.
    Eur J Clin Pharmacol; 1990 Aug 15; 39(4):419-21. PubMed ID: 2076730
    [Abstract] [Full Text] [Related]

  • 26. Sustained reductions in oxipurinol renal clearance during a restricted diet.
    Park GD, Berlinger WG, Spector R, Kitt TM, Tsalikian E.
    Clin Pharmacol Ther; 1987 Jun 15; 41(6):616-21. PubMed ID: 3581647
    [Abstract] [Full Text] [Related]

  • 27. Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.
    Day RO, Miners J, Birkett DJ, Graham GG, Whitehead A.
    Br J Clin Pharmacol; 1988 Oct 15; 26(4):429-34. PubMed ID: 3190993
    [Abstract] [Full Text] [Related]

  • 28. Absolute intramuscular, oral, and rectal bioavailability of alizapride.
    Houin G, Barre J, Tillement JP.
    J Pharm Sci; 1984 Oct 15; 73(10):1450-3. PubMed ID: 6502497
    [Abstract] [Full Text] [Related]

  • 29. [Experimental study of an ampicillin suppository (KS-R1) in adults and children].
    Motohiro T, Tanaka K, Koga T, Shimada Y, Tomita N, Sakata Y, Fujimoto T, Nishiyama T, Kuda N, Ishimoto K.
    Jpn J Antibiot; 1983 Jul 15; 36(7):1713-68. PubMed ID: 6655809
    [Abstract] [Full Text] [Related]

  • 30. Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals.
    Walter-Sack I, de Vries JX, Kutschker C, Ittensohn A, Voss A.
    Eur J Clin Pharmacol; 1995 Jul 15; 49(3):215-20. PubMed ID: 8665998
    [Abstract] [Full Text] [Related]

  • 31. Rectal bioavailability of lidocaine in man: partial avoidance of "first-pass" metabolism.
    de Boer AG, Breimer DD, Mattie H, Pronk J, Gubbens-Stibbe JM.
    Clin Pharmacol Ther; 1979 Dec 15; 26(6):701-9. PubMed ID: 498711
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Bioequivalence of allopurinol preparations: to be assessed by the parent drug or the active metabolite?
    Walter-Sack I, de Vries JX, Kreiner C, Ittensohn A, Stenzhorn G, Voss A, Weber E.
    Clin Investig; 1993 Mar 15; 71(3):240-6. PubMed ID: 8481628
    [Abstract] [Full Text] [Related]

  • 36. [The use of allopurinol in long-term treatments for optimal effect].
    Fenner H.
    Fortschr Med; 1980 Mar 13; 98(10):(373-6). PubMed ID: 7372221
    [Abstract] [Full Text] [Related]

  • 37. Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration.
    Anderson P, Arnér S, Bondesson U, Boréus LO, Hartvig P.
    Eur J Clin Pharmacol; 1981 Feb 13; 19(3):217-23. PubMed ID: 7215421
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Bioavailability of indomethacin after intramuscular injection and rectal administration of solution and suppositories.
    Jensen KM, Grenabo L.
    Acta Pharmacol Toxicol (Copenh); 1985 Nov 13; 57(5):322-7. PubMed ID: 4090993
    [Abstract] [Full Text] [Related]

  • 40. Clinical pharmacokinetics of allopurinol.
    Murrell GA, Rapeport WG.
    Clin Pharmacokinet; 1986 Nov 13; 11(5):343-53. PubMed ID: 3536254
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.